Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

FDA Biocompatibility Tips: Multiple Absorbability, Allergenicity Testing Methods To Choose From

This article was originally published in The Gray Sheet

Executive Summary

An FDA device reviewer and an agency toxicologist talk to The Gray Sheet about key industry considerations for biocompatibility testing, emphasizing a growing focus on testing absorbable implants and testing for allergens in devices.

Advertisement

Related Content

In Case You Missed It: Top 10 Gray Sheet Stories In April
CDRH Guidance Priorities Include Lab-Developed Tests, Adverse Event Reporting, Third-Party 510(k) Review
Novel Materials In Devices May Require Additional Biocompatibility Testing
Regulatory News In Brief

Topics

Advertisement
UsernamePublicRestriction

Register